Accendra Health (ACH) Cost of Revenue (2009 - 2026)

Accendra Health (ACH) has 18 years of Cost of Revenue data on file, last reported at $349.8 million in Q1 2026.

• On a quarterly basis, Cost of Revenue fell 1.38% year-over-year to $349.8 million in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 63.54% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, up 18.23% from the prior year.
• Cost of Revenue for Q1 2026 stood at $349.8 million, down from $385.7 million in the prior quarter.
• Over the last five years, Cost of Revenue for ACH reached as high as $2.1 billion in Q4 2022 and fell as low as -$4.9 billion in Q4 2023.
• Historically, Cost of Revenue has averaged $804.9 million across 5 years, with a median of $385.7 million in 2025.
• Across the five-year window, Cost of Revenue plunged 330.87% in 2023 and surged 5828.04% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $2.1 billion in 2022, then slumped by 330.87% to -$4.9 billion in 2023, then soared by 104.2% to $208.0 million in 2024, then jumped by 85.45% to $385.7 million in 2025, then declined by 9.32% to $349.8 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $349.8 million in Q1 2026, $385.7 million in Q4 2025, and $375.1 million in Q3 2025.